Data is not available at this time.
Vitalhub Corp. operates in the healthcare information services sector, delivering specialized technology solutions to health and human service providers across multiple geographies, including Canada, the U.S., the U.K., and Australia. The company’s core offerings encompass electronic healthcare records, case management, care coordination, and patient flow optimization tools, which enhance operational efficiency for healthcare institutions. By focusing on interoperability and mobile-enabled solutions, Vitalhub addresses critical gaps in healthcare IT infrastructure, positioning itself as a key enabler of digital transformation in the sector. Its diversified client base and recurring revenue model, driven by software subscriptions and maintenance services, provide stability amid evolving regulatory and technological demands. The company competes in a fragmented but growing market, leveraging its niche expertise in workflow optimization and data integration to differentiate from larger, generalized healthcare IT providers.
Vitalhub reported revenue of CAD 68.6 million in FY 2024, with net income of CAD 3.0 million, reflecting a net margin of approximately 4.4%. Operating cash flow stood at CAD 15.1 million, underscoring efficient cash conversion. Capital expenditures were modest at CAD -0.9 million, indicating a capital-light model focused on scalable software solutions rather than heavy infrastructure investments.
The company’s diluted EPS of CAD 0.0589 demonstrates modest but positive earnings power. With minimal debt (CAD 0.6 million) and robust cash reserves (CAD 56.6 million), Vitalhub maintains strong capital efficiency, allowing flexibility for organic growth or strategic acquisitions without overleveraging its balance sheet.
Vitalhub’s balance sheet is notably healthy, with cash and equivalents exceeding total debt by a wide margin. The negligible debt-to-equity ratio and high liquidity position the company to navigate macroeconomic uncertainties while funding innovation or market expansion initiatives.
Growth is primarily organic, supported by cross-selling and geographic expansion. The company does not pay dividends, reinvesting cash flows into product development and potential M&A to capture market share in the high-growth healthcare IT space.
At a market cap of CAD 548.6 million, Vitalhub trades at a premium to peers, reflecting investor confidence in its niche positioning and recurring revenue model. The beta of 0.791 suggests lower volatility relative to the broader market, aligning with its stable healthcare clientele.
Vitalhub’s strategic focus on interoperable, workflow-enhancing software aligns with global healthcare digitization trends. Its strong balance sheet and recurring revenue base provide resilience, while international expansion opportunities offer upside. Execution risks include competition from larger IT vendors and regulatory complexities in new markets.
Company filings, TSX disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |